The rating affirmation is based on a number of factors, including Halifax Health’s steady operating results and leading market share in its primary service area.
The outlook is stable.
Fitch has also affirmed Halifax Health’s following bonds:
- $115.1 million of series 2015 bonds at “BBB+”
- $42.7 million of series 2006A bonds at “BBB+”
- $107.9 million of series 2006B-1 and B-2 bonds at “BBB+”
- $70 million of series 2008 bonds at “BBB+”
More articles on healthcare finance:
RelayHealth financial reports 1.6% ICD-10 denial rate, MedAssets-Precyse launches new platform & more — 11 RCM key notes
California hospital to close after restructuring plan fails
From volume to value: The rules of the comprehensive joint replacement bundle
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.